An open label, randomized, single dose, 3-way crossover study to evaluate the pharmacokinetics of different dose levels and dose formulations of pegilodecakin in healthy adult participants.
To evaluate the pharmacokinetics of different dose levels and dose formulations of pegilodecakin in healthy adult participants.